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Abstract  
Background 
 It is challenging to understand mechanisms of drug resistance in Mycobacterium tuberculosis 
(MTB) due to the large variability in resistance associated genes. Efflux pump genes contribute 
to drug resistance and thus add to this complexity.  Efflux pumps gene protein superfamilies 
have been characterized by genome analysis of drug resistant strains and through in vitro 
transcriptional studies. However, there is limited information regarding efflux pump genes in 
extensively drug resistant (XDR) tuberculosis (TB) isolates. 
Methods 
Whole genome sequencing (WGS) based analysis of 37 extensively drug resistant (XDR) and 
five drug sensitive (DS) MTB clinical isolates was performed. Single nucleotide polymorphisms 
(SNPs) in efflux pump genes Rv0194, Rv1217, Rv1218, drrA, drrB, Rv1258, Rv1634, Rv2688, 
Rv1273, Rv1819, Rv1458, Rv1877 and Rv1250 were determined in the clinical isolates as 
compared with the H37Rv reference strain. Allele frequencies of SNPs identified in XDR strains 
were compared with DS strains. Gene expression of Rv0194, Rv2688, Rv1634, drrA and drrB 
was determined in XDR -TB isolates (n=9), DS-TB strains (n=4) and H37Rv. 
 
Results 
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We identified SNPs in XDR-TB isolates which were either unique or present at very low 
frequencies in DS strains; Rv0194 G170V; Rv1217 L151R; Rv1258 P369T and G391R; Rv1273 
S118G and I175T; Rv1877 I534T; Rv1250 V318X/A and S333A, and Rv2688 P156T. The 
expression of Rv2688 and drrB was found to be raised in XDR-TB as compared with DS-TB 
strains. 
Conclusions 
We identified some unique SNPs in efflux pump genes which may be associated with increased 
drug resistance in the isolates. Also increased levels of Rv2688 and drrB efflux pump genes in 
XDR strains even in the absence of antibiotics could make these clinical isolates more refractory 
to treatment. Further studies are required to directly associate these mutations with increased 
resistance in MTB.  
Keywords 
Extensively Drug Resistant, Mycobacterium tuberculosis, single nucleotide polymorphism, 
Efflux Pump
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Introduction 
Extensively drug resistant (XDR)-tuberculosis (TB) is caused by multidrug-resistant (MDR) 
Mycobacterium tuberculosis (MTB) strains (resistant to rifampicin (RIF) and isoniazid (INH)) 
which are also resistant to fluoroquinolone (FLQ) and one of the injectable aminoglycosides; 
amikacin (AMK), kanamycin (KAN) or capreomycin (CAP). In Pakistan, 4-5% of all TB cases 
are MDR and of these, 4-5% is XDR-TB [1, 2]. Resistance in MTB is mostly attributed to the 
acquisition of specific mutations in target genes [3-5]. Single nucleotide polymorphisms (SNPs) 
in rpoB, katG, gyrA, rrs, embB and pncA genes can result in resistance to RIF, INH, FLQ, AMK, 
ethambutol (EMB) and pyrazinamide (PZA) respectively. However, additional genes have also 
been shown to confer resistance to each of the above mentioned drugs, adding to the complexity 
of drug resistance in MTB. Efflux pumps are a likely alternative mechanism of resistance in 
MTB. 
Drug efflux has also been associated with pathogenicity, virulence, biofilm formation and 
coordination of gene expression in dense bacterial populations [6, 7]. Analysis of the available 
bacterial genomes has shown that putative drug efflux pumps (EPs) constitute 6% to 18% of all 
transporters found in any given bacterial cell. MTB presents one of the largest numbers of 
putative EPs compared to its genome size [8]. The mechanisms for the expression and regulation 
of these efflux pumps are not yet fully understood. Moreover, their role in drug resistance needs 
to be understood [9].  
Although efflux mechanisms have been studied in several mycobacteria [10-12] mostly, M. 
smegmatis has been used to study heterologous putative efflux pump genes [13-16]. In M. 
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smegmatis as well as in other mycobacteria, the cell wall, rich in mycolic acids, functions as an 
efficient barrier preventing the access of several molecules including antibiotics. However, this is 
not enough for explaining the innate drug resistance of these microorganisms [17].  
The first efflux pump described in mycobacteria was LfrA; belonging to the Major Facilitator 
Super-family (MFS) and which confers low-level resistance to fluoroquinolones, ethidium 
bromide, acridine and some quaternary ammonium compounds[18]. Other Efflux pumps initially 
characterized in mycobacteria were TetV conferring resistance to tetracycline [19] and Rv1258c 
which confers low-level resistance to aminoglycosides and tetracycline [10]. Adenosine tri 
phosphate ATP binding cassette (ABC) transporters are found both in prokaryotes and 
eukaryotes and constitute a large superfamily of multi-subunit permeases that transport amino 
acids, antibiotics and polysaccharides across biological membranes [13]. The ABC class of 
efflux pumps are primary transporters and are encoded by 2.5% of the genome of MTB. 
Sequence based analysis of MTB genomes has identified at least 12 putative ABC transporters 
which include: Rv0194, Rv1218c-Rv1217c, drrA-drrB-drrC, Rv1273c-Rv1272c, Rv2688c-
Rv2687c-Rv2686c, Rv1348-Rv1349, Rv1456c-Rv1457c-Rv1458c, Rv1473, Rv1667c-Rv1668c, 
Rv1686c-Rv1687c, Rv1819, Rv2477[20]. The common feature of all ABC transporters is the 
presence of two hydrophobic membrane spanning domains (MSDs) associated with two 
cytoplasmic nucleotide binding domains (NBDs). The MFS, small multidrug resistance (SMR), 
Resistance-Nodulation-Division (RND) and Multidrug and toxic compounds extrusion (MATE) 
members are secondary transporters, characteristically energized by the proton motive force (H+ 
or Na+)[21]. Rv1218c, an ABC class Efflux pump and Rv3065, of the SMR class have been 
shown to mediate the efflux of different chemical classes and antibiotics in M smegmatis[22]. 
Efflux pumps encoded by Rv0849 and Rv1258c also help extrude these compounds but to a 
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lesser extent in MTB[23]. The Rv1217c (MT1255)–1218c (MT1256): tetronasin-transport 
membrane protein ABC transporter, is composed of two copies of the Rv1218c, active as the 
nucleotide binding domain (NBD), and one copy of the Rv1217c, fused by two membrane-
spanning domains (MSDs)[21]. 
When overexpressed in M smegmatis, the Rv2686c-Rv2687c-Rv2688c ABC transporter has been 
shown to confer resistance to fluoroquinolones such as ciprofloxacin, with a 8 fold increase in 
the MIC for wild type MTB strains [15]. The Daunorubicin- phthiocerol dimycocerosates 
(DIMs)-transport ABC transporter operon comprises drrA (Rv2936) which is the NBD and drrB 
(Rv2937) which encodes the membrane integral component [24]. The drr operon plays a 
significant role in the virulence of MTB [25], it is an important drug target and exports a surface 
antigenic lipid known as DIMs to the cell surface [26]. Rv0194 is an ABC multidrug efflux pump 
which can increase resistance in M bovis BCG to several other antibiotics [27].  
Based on sequence analysis, at least 16 putative MFS efflux pump genes have been identified in 
MTB which include: Rv0037c, Rv0191, Rv0783c, Rv0849, Rv1250, Rv1258c, Rv1410c, Rv1634, 
Rv1877, Rv2333c, Rv2456c, Rv2459, Rv2846c (efpA), Rv28994, Rv3239c and Rv3728 [19].  
 
Whilst many studies describe efflux pump genes and their over-expression in response to anti-
tuberculous drugs, there is limited information regarding mutations in the genes. Garima et al. 
identified SNPs in ten efflux pump genes (Rv1877, Rv1634, Rv1250, Rv0194, Rv1273, Rv1458, 
Rv1819, Rv0507, Rv3832, Rv0676) by comparing a MDR TB strain sequence with H37Rv and 
showed the same genes to be over-expressed in response to INH and RIF treatment [28]. Li et al, 
compared the gene expression of 20 putative efflux pump genes between MDR and pan sensitive 
clinical isolates, to find that in MDR isolates the basal levels of some of these efflux pumps 
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genes were higher even without drug inducement [29]. To date there is limited information 
describing efflux pump genes in XDR TB strains. In this study, we analysed whole genome 
sequence (WGS) data of XDR MTB clinical strains for non-synonymous (nsSNPs) in efflux 
pump genes belonging to mainly the ABC and MFS super families; Rv0194, Rv1217, Rv1218, 
Rv1258, drrA, drrB, Rv1634, Rv2688, Rv1273, Rv1819, Rv1458, Rv1877 and Rv1250. These 
were genes in which SNPs had been previously described and/ or had been shown to be over-
expressed in response to antibiotic treatment. We also investigated the transcription levels of 
efflux pump genes Rv0194, Rv1634, Rv2688, drrA and drrB in XDR isolates as compared with 
pan sensitive clinical isolates and H37Rv.  
 
Materials and Methods 
This study was approved by the Ethical Review Committee, The Aga Khan University. 
XDR-TB isolates 
XDR-TB strains (n=37) and drug sensitive strains (DS) (n=5) were obtained from the Aga Khan 
University Clinical Microbiology laboratory strain bank and have been described previously 
[30]. The XDR strains comprised mainly CAS family isolates: CAS1-Delhi (n=20), CAS (n=2) 
and CAS2 (n=1); others were EAI3-IND (n=2), X3 (n=1), T1 (n=3) and other lineage 1 and other 
lineage 3 isolates (n=8) lineages [29]. The DS clinical strains belonged to the CAS1-Delhi 
lineage. 
Whole gene sequencing analysis 
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Briefly, all samples underwent WGS with 76-base paired end fragment sizes, using Illumina 
paired end HiSeq2000 technology, and the raw sequence data is available in the European 
nucleotide archive (http://www.ebi.ac.uk/ena/data/view/ PRJEB7798). XDR genome data was 
mapped to H37Rv reference genome (Genbank accession: AL123456.3) using bwa-mem 
software and variants called using SAMtools (http://samtools.sourceforge.net)[31, 32].  
Resistance associated genes previously evaluated in the 37 XDR and 5 DS-Pak strains were; 
rpoB, rpoC, rpoA, katG, inhA, fbpC, Rv1392c, ndh, Rv2242, fabD, kasA, accD, oxyR, fadE24, 
ndh, Rv1772, gyrA, gyrB, rrs, tlyA, ethA, fabG1, rpsL, gidB, pncA, embB, embA, embC, 
Rv3124, rmlD, iniA, iniB, iniC, PPE49 and manB [29]. In addition, we investigated embA_pro, 
ubiA, fabG1_pro, eis_pro mutations. SNPs identified in MTB isolates are listed in 
Supplementary Table 2.  
Efflux pump genes annotations are as per the MTB genome [33] available at 
www.sanger.ac.uk/Projects/M_tuberculosis/Gene_list/functional_classes/III.A.6.shtml. 
Previously published Artemis Comparison Tool (ACT)[34] was used to identify nsSNPs in the 
open reading frames of target genes. A maximum likelihood phylogenetic tree was created with 
RAxML using all SNPs present in the XDR isolates. 
Allele frequencies of the SNPs identified in efflux pump genes of XDR strains were determined 
in a cohort of 1,526 drug susceptible isolates from Karonga, Malawi [35]. The data set is 
publically available at the EBI European Nucleotide Archive 
(http://www.ebi.ac.uk/ena/data/view/ERP000436). Sample genotypes were called using the majority 
allele (minimum frequency 75%) in positions supported by at least 20-fold coverage; otherwise 
we classified them as missing (thus ignoring heterozygous calls). 
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Culture and determination of minimum inhibitory concentrations (MICs) 
MTB strains were isolated from Lowenstein-Jensen media and MGIT (Becton Dickinson, 
Franklin Lakes, NJ, and USA). MTB was identified using BACTEC NAP TB differentiation test 
(Becton Dickinson), growth on para-nitrobenzoic acid containing media, nitrate reduction, and 
niacin accumulation [36]. Drug Susceptibility Testing (DST) of these isolates was performed 
using the agar proportion method on enriched Middlebrook 7H10 medium (BBL Microbiology 
Systems, Cockeysville, MD, USA) as per Global TB Programme (WHO) guidelines for first-line 
and second-line DST [37]. Concentrations used were: RIF 1 µg/mL, INH 0.2 µg/ml, 
streptomycin (STR) 2 µg/ml, and EMB 5 µg/ml. Pyrazinamide (PZA)  sensitivity was 
determined by using BACTEC 7H12 medium, pH 6.0, at 100 µg/mL (BACTEC PZA test 
medium, Becton Dickinson). MDR TB strains were further tested with ofloxacin (OFX) 2ug/ml, 
CAP 4µg/ml, AMK 4µg/ml, KAN 5µg/ml and ethionamide (ETH) 5µg/ml. The reference strain 
MTB H37Rv was used as a control with each susceptibility testing batch[38]. 
DNA extraction 
MTB isolates grown on Middlebrook 7H10 medium were inoculated in 500ul of 1X Tris EDTA 
(TE) buffer. The MTB cell suspension was heat killed at 850C for 30mins in a sonicating water 
bath. The sample was centrifuged at 13,000 g for 5 min, and the supernatant was discarded. 
Cellular pellets were processed for DNA extraction was performed using the cetyl-trimethyl 
ammonium bromide (CTAB) method [39].  
RNA extraction and reverse transcription 
MTB isolates were grown to log phase in Middlebrook medium. MTB was heat killed at 850C 
for 30mins in a sonicating water bath. The sample was centrifuged at 13,000 g for 5 min, and the 
supernatant was discarded. RNA was extracted using Trizol reagent (Invitrogen, USA) as per the 
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manufacturer’s recommendations. One microgram of RNA was reverse transcribed using 
Moloney Murine Leukemia Virus (M-MuLV, MMLV) Reverse Transcriptase (Invitrogen, USA) 
as described previously[40].  
The cDNA was stored in aliquots at -350C and 2µl of cDNA were used in each PCR reaction.  
Real time PCR was performed in duplicate 20µl reactions containing Platinum SYBR Green 
qPCR Supermix-UDG (Invitrogen). Forward and Reverse primers at a final concentration of 
10pmole/µl. The forward and reverse primers for SYBR real time PCR for Rv1634, drrA and 
drrB efflux pump genes were taken from Li et al, PLoS One, 2015[29]; 16S RNA from Sarathy et 
al, PLoS One, 2013[41]. The primer sequences for Rv2688 (Forward: 
CACGGTGTGGGACAAAGA, Reverse: AGAAGCGCAGGTTCTCATAC); Rv0194: (Forward: 
GTCCACTATTCCTACCGAACAC, Reverse: TTGATCAGGGTGGATTTCCC).  
All PCRs were run at 94°C for 15 min; 45 cycles at 950C for 30s, annealing at 600C for (drrA 
and drrB); 570C (Rv0194); 560C (Rv1634); 580C (Rv2688) followed by extension at 720C for 
30s. Target amplification was determined by melting curve analysis. 
 
Quantification of gene expression using SYBR Green real-time quantitative PCR (qPCR) 
Efflux pump gene expression was compared between nine XDR strains and five drug susceptible 
MTB strains (H37Rv and four clinical isolates). Fold change was calculated by 2-∆∆CT method 
of Livak and Schmittgen [42]. 16S RNA was used as used as a control gene to calculate the ∆CT 
values for individual samples. Differences in threshold cycle (∆CT) values for each gene were 
obtained by subtracting the CT value of 16S RNA in each case.  
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PCR was performed in duplicates for each gene. The relative amount of gene transcripts was 
calculated using the 2-∆∆CT method as described [42].   These values were then used to 
calculate the relative expression of efflux pump mRNA in each of the samples tested [42].  
Data analysis 
GraphPad Prism 5.0 was used to perform Mann-Whitney test, and the difference was considered 
to be statistically significant when P < 0.05.  
Results 
We first analysed the genome sequence data obtained for 37 XDR-TB and 5 drug sensitive 
strains.  According to lineage characterization, the representation of XDR-TB strains was largely 
from Lineage 3 (75.7 %) followed by Lineage 1 (13.5%) and Lineage 4 (10.8%) isolates 
(Supplementary Table 1). The relatedness between the XDR strain lineages as per their SNPs is 
depicted in a phylogenetic tree (Figure 1). The SNPs in the XDR strains were largely associated 
with their lineage groups.   
Further we focused on SNPs in putative efflux pump genes belonging to two superfamilies of 
genes found in Mycobacterium sp., ABC transporters and MFS proteins. These were; Rv0194, 
Rv1217, Rv1218, Rv1258, drrA, drrB, Rv1634, Rv2688, Rv1273, Rv1819, Rv1458, Rv1877 and 
Rv1250. SNPs identified in the candidate efflux pump genes in XDR strains were compared with 
our WGS data from drug susceptible clinical isolates, see Table 1.  
To further investigate the relevance of SNPs identified in target efflux pumps from the XDR 
analysis, data of 1,526 drug susceptible isolates from Karonga, Malawi was also analysed for the 
SNPs of interest identified from the XDR analysis [35]. The isolates from Malawi comprised 
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16% Lineage of 1, 5% Lineage of 2, 11% of Lineage 3 and 68% of Lineage 4 strains. The 
frequency of the SNPs compared with the larger data set of Karonga isolates is depicted in Table 
2 with 0.1 as a cut-off for common alleles [35].  
Rv0194 gene 
Sequence analysis of Rv0194 showed that the SNP M74T was present in all XDR strains and the 
4 DS-TB (Pakistan, Pak) strains (Table 1). M74T was also present at a frequency of 0.95 in 
Karonga strains (Table 2). However, one XDR strain (Lineage 1, X17) had a G170V change 
which was not present in the DS-TB (Pak) strains. Rv0194 G170V was present at a low (0.04) 
frequency in the DS-Malawi set (Table 2).  
Rv1217 efflux pump gene 
The WGS comparisons of Rv1217 revealed that one XDR EAI-3-IND strain (X32) had a 41 bp 
deletion at nt+1361325. Another XDR strain (Lineage 1, X49) had Rv1217 L151R which was 
not present in the DS-Pak strains and was only found at 0.03 frequency in the DS-Malawi set. 
X49 also had the drrA SNP H309D (Table 1). 
 Rv1218 efflux pump gene 
Thirty-three (89%) of XDR and all four CAS DS-Pak strains had Rv1218 Q243R. Of the four 
XDR strains that did not have Q243R, three belonged to T1 and one to the CAS1-Delhi lineage. 
Rv1218 SNP Q243R was found at frequency of 0.39 in the DS-Malawi data set.  
Polymorphism in Rv1258 efflux pump gene 
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One XDR strain (Lineage 1, X57) had Rv1258 G391R, drrA H309D and was resistant to eight 
drugs (Table1). Another XDR strain (X47) with Rv1258 P369T was resistant to all ten drugs 
tested. Neither Rv1258 G391R nor P369T were found in DS-Pak or DS-Malawi isolates (Table 
2).  
drrA efflux pump gene 
Five XDR Lineage 1 strains (X5, X17, X49, X32 and X57) had drrA H309D. Two of these XDR 
strains belonged to EAI-IND lineage and three were ‘Other Lineage 1’ isolates.  This SNP was 
present at a frequency of 0.16 in DR-Malawi isolates. It is likely to be a lineage associated SNP 
as the 5 XDR strains we describe here clustered within a two nodes of relatedness (Fig 1).  
Rv1634 efflux pump gene 
Analysis of Rv1634 revealed I47V in three of above described Lineage 1 strains (X49, X32 and 
X5) (Table 1) which clustered together (Fig. 1). This SNP was present at a frequency of 0.16 in 
DRS isolates.  
Rv2688 
We found the Rv2688 SNP P156T in each of the XDR strains we studied. This SNP was not 
present in the DS-Pak isolates but was found at a frequency of 0.08 in the DS-Malawi isolates.  
Rv1273 
The Rv1273 SNP G462K was present in 29 XDR strains, in all five DS-Pak strains and in 11 % 
of DS-Malawi strains. A ‘lineage 1’ XDR isolate (X17) had SNPs Rv1273 S118G and I175T. 
Another ‘lineage 1’ XDR strain (X57) had Rv1273 I175T.  Rv1273 S118G was also observed in 
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a CAS1-Delhi XDR strain (X55). Neither Rv1273 S118G nor I175T were observed in the DS-
Pak and DS-Malawi data sets. There appeared to be no phylogenetic relationship between X55 
and X57 (Fig 1) although both had Rv1273 S118G. 
Rv1819 
Rv1819 I603V has previously been identified by Garima et al in MDR strains [28]. The SNP was 
also present at a frequency of 0.16 in DS-Malawi strains. We found the combination of Rv1819 
I603V and drrA H309D SNPs to be present in the five Lineage 1 (clustered) XDR strains 
described earlier suggesting, that these SNPs may be associated with a common lineage. 
Rv1458 
We did not identify any SNPs in the Rv1458 in the XDR or DS-Pak isolates studied. 
Rv1877 
The Rv1877 I534T SNP was present in two XDR strains belonging to ‘lineage 1’. This SNP was 
not present in DS-Pak strains and had a 0.04 allele frequency in the DS-Malawi isolates.  
Rv1250 
Four different SNPs were observed in Rv1250. We found R278G to be present in 5 XDR strains. 
The R278 SNP has been mentioned by Garima et al to be a high confidence mutation [28]. 
However, we also found it at a frequency of 0.16 in the DS-Malawi set. Three XDR strains had 
unique Rv1250 SNPs A196T, V318X/A and S333A which were not present in any DS-Pak 
isolate studied.  
Associating Lineage specific SNPs with resistance genotypes  
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To summarise, we found a combination of SNPs; Rv1634 I47V, drrA H309D and Rv1819 I603V 
in five Lineage 1 XDR isolates (X5, X17, X32, X49 and X57). We also observed that the ubiA 
E149D SNP was also present in the abovementioned strains. As these XDR strains clustered 
together in a phylogenetic tree (Fig. 1) the abovementioned SNPs can be considered to be related 
to a common lineage.  
Further, we looked for particular genotypes related to efflux pumps which could possibly be 
associated with dug resistance. We analysed the XDR strains for common drug resistance 
conferring mutations related to flouroquinolone, aminoglycoside and streptomycin. Eight of the 
XDR strains (X5, X11, X16, X32, X37, X40, X49 and X58) did not have any gyrA mutations, 
Supplementary Table 2. Five XDR strains (X32, X42, X43, X49 and X56) resistant to 
AMK/KAN did not present with any rrs (1400 region) mutations. Fourteen XDR strains were 
phenotypically resistant to STR but did not display rrs (500 region) or rpsL mutations. 
In the context of unique or low frequency efflux pump SNPs, nine XDR strains had one or more 
SNP in an efflux pump gene which has been associated with increased resistance to anti-
tuberculous drugs (Table 3). As all of these strains presented with a combination of efflux pump 
gene mutations (Table 1) it is quite possible that these SNPs have contributed to resistance in the 
XDR isolates. 
Quantification of basal mRNA expression levels of Rv1634, Rv2688, drrA and drrB and 
Rv0194 efflux pump genes in XDR MTB strains 
Nine XDR-TB strains from the overall XDR strains were randomly selected for transcriptional 
studies. We were able to re-grow four of the five drug susceptible strains (for which WGS data 
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was available) thus, these four strains and H37Rv were included as pan sensitive isolates for the 
gene expression study.  
We investigated particular efflux pump genes by determining their expression levels in XDR-TB 
isolates as compared with drug susceptible clinical isolates, in the absence of antibiotic selection 
pressure. Efflux pump genes Rv0194, Rv1634, Rv2688, drrA and drrB was chosen as these 
belonged to ABC-type transporter and MFS superfamilies which have previously been shown to 
be upregulated in drug resistant MTB strains. We studied nine XDR strains across different 
lineages; X5 was from EAI-IND, X9, X10, X42, X55 and X61 were from CAS1-Delhi and X49, 
X57 and X60 were from Orphan lineages. XDR strains were compared with five drug 
susceptible strains, 4 pan-susceptible CAS1-Delhi strains and H37Rv.  
When the gene expression in XDR and drug sensitive strains was compared it was apparent that 
mean basal mRNA expression levels of Rv2688c (p=0.0108) and drrB (p=0.0166) were 
significantly higher in the XDR as compared with drug susceptible MTB strains (Figure 2). 
However, no significant differences were observed in the mRNA levels of Rv0194 (p=0.1643), 
Rv1634 (p=0.1891) and drrA (p=0.1891) respectively between XDR and DS MTB strains 
(Figure 2).  
 
Discussion  
We focused on efflux pumps belonging to the larger families of transport proteins; ABC and 
MFS types and those which have been well studied and shown to contribute to antibiotic 
resistance in MTB.  By determining nsSNPs in selected efflux pump genes in XDR strains and  
comparison with DS strains we have identified a number of SNPs which could potentially be 
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associated with drug resistance. We first identified SNPs in efflux pump genes Rv0194, Rv1217, 
Rv1218, Rv1258, drrA, drrB, Rv1273, Rv1634, Rv1819, Rv2688, Rv1273, Rv1819, Rv1877 
Rv1250 and Rv1458.  Through the comparison of data sets we identified alleles which were 
either unique to XDR strains or were present at a very low frequency in DS-TB strains.  The 
Pakistan strains comprised mainly of lineage 1 and 3 strains. The African MTB strains 
comprised a different proportion of lineage isolates but as the data set was fairly large (n=1526), 
there was substantial representation of strains including, lineage 1 and 3 strains. Through this 
work we excluded a number of SNPs previously been labeled as high confidence mutation by 
comparison between H37Rv and a reference MDR-TB sequence [28].  
Firstly, we identified SNPs in efflux pump genes Rv0194, Rv1217, Rv1218, Rv1258, drrA, drrB, 
Rv1273, Rv1634, Rv1819, Rv2688, Rv1273, Rv1819, Rv1877 and Rv1250 and but not in drrB or 
Rv1458. Further comparison with DS-Pak and DS-Malawi isolates revealed a sub-set of unique 
and low frequency alleles in seven of the efflux pump genes; Rv0194, Rv1217, Rv1258, Rv2688, 
Rv1273, Rv1877 and Rv1250 respectively.   
The Rv0194 SNP G170V was present in a single XDR strain belonging to the ‘Other Lineage 1’ 
family. The role of Rv0194 in efflux of beta lactams such as vancomycin and tetracycline [27] 
has been shown but as yet this efflux pump has not been associated with rifampicin, isoniazid or 
any other second line anti-TB drugs in MDR or XDR-TB strains.  
One ‘Other lineage 1’ isolate had Rv1217 SNP L151R whilst another had a 40 nucleotide 
deletion in Rv1217.  Rv1217-Rv1218 operon is ABC transporter shown to play a role in 
mediating antibiotic resistance in M. smegmatis [22]. Rv1218 and Rv1273 genes have been 
shown to be upregulated in MDR isolates which did not have rpoB or katG mutations [43] 
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suggesting, it plays a role in MDR resistance. Two XDR strains had Rv1273 S118G which has 
been reported previously in association with STR and EMB drug resistance [28]. 
The Rv1258 SNP G391R was present in an Orphan strain and P369T in a CAS1 strain.  Rv1258 
encodes a tetracycline/aminoglycoside resistance -like efflux pump [10, 44] and is found to be 
upregulated in MDR-TB under rifampicin pressure [45]. 
Rv1634 belongs to the Major facilitator superfamily (MFS) and has been reported to decrease 
susceptibility to various fluoroquinolones when overexpressed in M. smegmatis and is involved 
in norfloxacin and ciprofloxacin efflux [46]. Rv1634 efflux pump gene has also been shown to be 
upregulated in MTB strains after exposure to RIF [29].  
Drr proteins of MTB are suggested to be involved in the export of complex lipids 
dimycocerosates (DIM) to the cell surface in MTB [47]. Previously, it was reported that drrA 
was overexpressed in MDR isolates induced by INH and zero MDR isolates induced by RIF, 
suggesting that drrA was one of the factors for INH resistance in MTB [29].   
The Rv1877 SNP I534T has been reported previously in resistant strains and Rv1877 gene 
expression is shown to be upregulated in drug resistant MTB [28].  
We described five Lineage 1 XDR strains with a combination of drrA SNP H309D, Rv1634 SNP 
I74V and ubiA  E149D. Ethambutol resistance has previously been associated with ubiA gene 
mutations and it has been previously shown that E149D was present with resistant isolates only 
[48]. Association of the above mentioned SNPs with lineages was demonstrated by the clustering 
of lineage 1 XDR strains which had a unique subset of SNPs. 
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Streptomycin resistance is thought to be associated with rpsL, rrs (500 region) mutations. gidB 
polymorphism is associated with low level of streptomycin resistance in MTB [49]. We found 
that 11 isolates were STR resistant but did not have rpsL, rrs (500 region) mutations. Also, there 
were eight OFX resistant isolates which did not have mutations in gyrA genes and there were 
five KAN/AMK resistant isolates without mutations in the rrs (1400 region). It may be that the 
combination of the efflux pump gene associated SNPs may have an additive effect on drug 
resistance of the XDR isolates, so that they become resistant to a range of anti-tuberculous drugs.  
mRNA expression analysis of the Rv0194, Rv2688, Rv1634, drrA and drrB basal mRNA chosen 
efflux pump genes revealed that Rv2688 and drrB gene expression was increased in XDR strains 
as compared with drug susceptible isolates. In the nine XDR strains studied, none had SNPs in 
the drrB gene. However, all the XDR strains had the Rv2688 SNP P168T. There were no drrB or 
Rv2688 SNPs present in the drug susceptible isolates studied. We found significantly increased 
(p<0.05) basal level mRNA expression levels of expression levels in XDR MTB strains as 
compared with the susceptible clinical isolates and the H37Rv laboratory strain.  
The upregulation of Rv2688 has been associated with flouroquinolone resistance as it was 
observed that the Rv2688 along with Rv2686 and Rv2687 actively pumped out ciprofloxacin[15].  
Previous reports have shown reduced mRNA expression of Rv1877, Rv2265 and MmpL13a in 
MDR MTB strains as compared with pan sensitive MTB strains, with the suggestion that these 
efflux pumps regulate intracellular levels of nutrients and cofactors but not pump out anti-TB 
drugs [29]. 
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We have identified novel SNPs in efflux pump genes that could be associated with drug 
resistance however, further work needs to be done so that this association can be confirmed. We 
were not able to perform gene expression analysis of all the efflux pump genes in which SNPs 
were identified and this could be done in the future. This data provides important insights into 
the variability of efflux pump related SNPs and their potential role in increasing drug resistance 
in MTB. 
Conclusion 
Overall, our data identifies unique SNPs in efflux pump genes Rv0194, Rv1217, Rv1250, Rv1877 
and Rv1273. As these were not found in drug susceptible strains these may be associated with 
alternate mechanism of drug resistance in XDR-TB strains. The upregulation of efflux pump 
genes in the absence of antibiotic pressure further points to the important role of efflux pump 
proteins in the acquisition and maintenance of drug resistance in MTB isolates. 
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Figure Legends 
Figure 1. Phylogenetic tree of XDR isolates. A maximum likelihood phylogenetic tree was 
created with RAxML using all SNPs in our isolates. XDR-TB strains (n=37) are identified by 
numbers and also their lineages. Central Asian Strain (CAS), East African Indian (EAI), Other 
Lineage (Ot. Lin.) for those which had in silico profiles similar to primary lineage families. 
 
Figure 2. Gene expression of efflux pumps in DR and drug susceptible (DS) MTB strains. The 
figure depicts the relative mRNA expression of Rv0194, Rv1634, Rv2688c, drrA and drrB genes 
in XDR MTB strains (n=9) as compared with DS MTB strains (n=4). The results from real-time 
PCR showed no significant differences (p>0.05) in mean basal level mRNA expression levels of 
(A) Rv0194 (B) Rv1634 and (D) drrA efflux pump genes. The differences in mean basal level 
mRNA expression levels for (C) Rv2688c and (E) drrB were significantly higher (p<0.05)  
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Table1: An Overview of Non-synonymous SNPS (nsSNPs) in efflux pump genes of XDR MTB Isolates From Pakistan
Isolates ID Spoligo Lineage Rv1218 drrA Rv1634 Rv2688 Rv1819 Rv1877 Rv1458
Position Position Position Position Position Position
227098 227386 1361325 1361350 1362006 1406170 1406236 3273138 1839306 3005185 1422667 1423527 1423699 2062922 2127504
1394764 1395010 1395131 1395175
EP1 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - - G462K - - - - - - - - -
EP2 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - - G462K - - - - - - - - -
S4 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - - G462K - - - - - - - - -
S5 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - - G462K - - - - - - - - -
C3 CAS1-Delhi Lineage3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X1 Other lineage 3 Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X4 CAS2 Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X5 EAI3-IND Lineage 1 M74T - - - Q243R - - H309D I47V P156T - - - I603V - - R278G - - -
X6 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X7 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X8 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X9 Other lineage 3 Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X10 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X11 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X12 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X13 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T
G462K
- - - - - - V318X - -
X14 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X16 CAS1-Delhi Lineage 3 M74T - - - - - - - - P156T - - - - - - - - - -
X17 Other lineage 1 Lineage 1 M74T G170V - - Q243R - - H309D - P156T - I175T
S118G I603V I534T
- R278G - - -
X18 CAS Lineage 3 M74T - - - Q243R - - - - P156T - - - - - A196T - - - -
X21 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T
G462K
- - - - - - - -
X22 CAS Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - A196T - - - -
X32 EAI3-IND Lineage 1 M74T - ∆ - Q243R - - H309D I47V P156T - - -
I603V
- - R278G - - -
X33 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - V318A - -
X37 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T
G462K
- - - - - - - S333A S333A
X39 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X40 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T
G462K
- - - - - - - - -
X41 T1 Lineage 4 M74T - - - - - - - - P156T - - - - - - - - - -
X42 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X43 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X44 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X45 Other lineage 3 Lineage 3 M74T - - - Q243R - - - - P156T
G462K - - - - - - - - -
X46 X3 Lineage 4 M74T - - - Q243R - - - - P156T - - - - - - - - -
X47 CAS1-Delhi Lineage 3 M74T - - - Q243R - P369T - - P156T
G462K
- - - - - - - - -
X48 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X49 Other Lineage 1 Lineage 1 M74T - - L151R Q243R - - H309D I47V P156T - - -
I603V
- - R278G - - -
X55 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - S118G - - - - - - -
X56 T1 Lineage 4 M74T - - - - - - - - P156T - - - - - - - - - -
X57 Other Lineage 1 Lineage 1 M74T - - - Q243R G391R H309D - P156T - I175T - I603V I534T - R278G - - -
X58 T1 Lineage 4 M74T - - - - - - - - P156T - - - - - - - - - -
X60 Other lineage 3 Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
X61 CAS1-Delhi Lineage 3 M74T - - - Q243R - - - - P156T G462K - - - - - - - - -
CAS1: Central Asian Strain1;EAI: East African Indian; OPN: Orphan; T1: Undefined Group; X-family;∆ denotes deletion; X denotes unknown change
Rv0194 Rv1217 Rv1258 Rv1273 Rv1250
Position Position Position Position
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Table 2. Frequency of efflux pump gene polymorphisms in susceptible M. tuberculosis isolates 
Gene 
name Chr pos codon_position nucleotide_alleles amino_acid_alleles frequencies 
Rv0194 227098 74 C,T T,M 0.95,0.05 
Rv0194 227386 170 T,G V,G 0.04,0.96 
     
 
Rv1217c 1361350 151 A,C L,R 0.97,0.03 
            
Rv1218c 1362006 243 C,T R,Q 0.39,0.61 
            
Rv1258c 1406170 391 C G 1 
Rv1258c 1406236 369 G P 1 
            
Rv2936 
(drrA) 3273138 309 C,G H,D 0.84,0.16 
            
Rv1634 1839306 47 A,G I,V 0.88,0.12 
            
Rv2688c 3005185 156 T,G T,P 0.92,0.08 
            
Rv1273 1422666 462 C,T G,E/R 0.89,0.11 
Rv1273 1423527 175 A I 1 
Rv1273 1423699 118 C,T G,S 0.02,0.98 
            
Rv1819 2062922 603 C,T V,I 0.16,0.84 
            
Rv1877 2127504 534 C,T T,I 0.04,0.96 
            
Rv1250 1394764 196 G A 1 
Rv1250 1395010 278 A,G R,G 0.84,0.16 
Rv1250 1395131 318 T V 1 
Rv1250 1395175 333 T S 1 
 
The frequencies are those found in a dataset of 1526 drug susceptible isolates from Karonga, Malawi 
[35]. Significant allele frequencies (in bold) are based on a cut-off of 0.1. 
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Table 3. XDR TB strains with unique SNPs in efflux pump genes 
XDR strain Lineage No of ATT drugs to 
which it is Resistant 
Efflux gene SNP 
profile 
X13 CAS1-Delhi I R P S E F K Ak Rv1250 V318X 
X17 Other 
Lineage 1 
I R P S E F K Ak Rv0194 G170V; 
Rv1273 S118G, 
I175T; Rv1877 I534T  
X32 EAI3-IND I R P E F Cap K Ak 
Em 
Rv1217 del 41nt 
X33 CAS1-Delhi I R P S E F Cap K 
Ak  
Rv1250 V318A 
X37 CAS1-Delhi I R P S E F K Ak Rv1250 S333A 
X47 CAS1-Delhi I R P S E F Cap K 
Ak Em* 
Rv1258 P369T 
X49 Other 
Lineage 1 
I R P F K Ak Rv1217 L151R 
X55 CAS1-Delhi I R P S E F K Ak Rv1273 S118G 
X57 Other 
Lineage 1 
I R P S E F K Ak Rv1258 G391R; 
Rv1273 I175T; 
Rv1877 I534T 
# I=Isoniazid, R= Rifampicin, P= Pyrazinamide, S= Streptomycin, E= Ethambutol, F= 
Fluoroquinolones, Cap= Capreomycin, K= Kanamycin, Ak= Amikacin, Em= Ethionamide;   * 
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p=0.0166
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